{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:17:38Z","timestamp":1760645858761},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.transproceed.2011.05.032","type":"journal-article","created":{"date-parts":[[2011,8,13]],"date-time":"2011-08-13T09:15:54Z","timestamp":1313226954000},"page":"2365-2378","source":"Crossref","is-referenced-by-count":5,"title":["Alemtuzumab Induction in Deceased Donor Kidney Transplantation"],"prefix":"10.1016","volume":"43","author":[{"given":"M.","family":"Shin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.H.","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.H.","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.W.","family":"Joh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.-K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.-J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2011.05.032_bib1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/01.tp.0000166921.14670.33","article-title":"Randomized trial of Alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation","volume":"80","author":"Vathsala","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2011.05.032_bib2","first-page":"41","article-title":"The evolving role of alemtuzumab (Campath-1H) in renal transplantation","volume":"3","author":"Pham","year":"2009","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.transproceed.2011.05.032_bib3","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/j.1600-6143.2005.00822.x","article-title":"Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation\u2013efficacy and safety at five years","volume":"5","author":"Watson","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2011.05.032_bib4","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.transproceed.2008.02.026","article-title":"Experience with Alemtuzumab (Campath-1H) as induction agent in renal transplantation followed by steroid-free immunosuppression","volume":"40","author":"Baez","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2011.05.032_bib5","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/01.TP.0000128625.29654.EB","article-title":"The use of Campath-1H as induction therapy in renal transplantation: preliminary results","volume":"78","author":"Ciancio","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2011.05.032_bib6","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1111\/j.1600-6143.2005.01123.x","article-title":"Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free kidney transplant immunosuppression","volume":"5","author":"Flechner","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2011.05.032_bib7","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1111\/j.1600-6143.2006.01495.x","article-title":"Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy","volume":"6","author":"Tan","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2011.05.032_bib8","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/j.1600-6143.2008.02273.x","article-title":"Alemtuzumab (Campath-1H) and tacrolimus monotherapy after renal transplantation: results of a prospective randomized trial","volume":"8","author":"Margreiter","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2011.05.032_bib9","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1097\/01.tp.0000239268.64408.84","article-title":"Recipient memory-like lymphocytes remain unresponsive to graft antigens after CAMPATH-1H induction with reduced maintenance immunosuppression","volume":"82","author":"Trzonkowski","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2011.05.032_bib10","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/j.1432-2277.2006.00382.x","article-title":"Different mechanisms of Campath-1H-mediated depletion for CD4 and CD8 T cells in peripheral blood","volume":"19","author":"Lowenstein","year":"2006","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2011.05.032_bib11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.transproceed.2009.12.046","article-title":"Evaluation of late immunologic parameters among renal transplant recipients induced with Campath-1H","volume":"42","author":"Alba","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2011.05.032_bib12","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1016\/j.transproceed.2008.03.066","article-title":"Alemtuzumab induction in kidney transplantation: clinical results and impact on T-regulatory cells","volume":"40","author":"Morales","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2011.05.032_bib13","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1600-6143.2007.02134.x","article-title":"CD4+ CD25+ FOXP3+ regulatory T cells increase de novo in kidney transplant patients after immunodepletion with Campath-1H","volume":"8","author":"Bloom","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2011.05.032_bib14","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1681\/ASN.2006101143","article-title":"Regulatory T cells and T cell depletion: role of immunosuppressive drugs","volume":"18","author":"Noris","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2011.05.032_bib15","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1097\/01.tp.0000295718.55669.3a","article-title":"Subcutaneous administration of alemtuzumab in simultaneous pancreas-kidney transplantation","volume":"84","author":"Clatworthy","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2011.05.032_bib16","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/01.TP.0000161221.17627.8A","article-title":"Calcineurin inhibitor- and steroid-free immunosuppression in pancreas-kidney and solitary pancreas transplantation","volume":"79","author":"Gruessner","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2011.05.032_bib17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00007890-199907270-00018","article-title":"A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation","volume":"68","author":"van Gelder","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2011.05.032_bib18","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/TP.0b013e318163619f","article-title":"Campath-1H induction therapy in African American and Hispanic first renal transplant recipients: 3-year actuarial follow-up","volume":"85","author":"Ciancio","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2011.05.032_bib19","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.surg.2004.06.015","article-title":"Campath-1H in renal transplantation: The University of Wisconsin experience","volume":"136","author":"Knechtle","year":"2004","journal-title":"Surgery"},{"key":"10.1016\/j.transproceed.2011.05.032_bib20","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1432-2277.2006.00343.x","article-title":"The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation","volume":"19","author":"Magliocca","year":"2006","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2011.05.032_bib21","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jamcollsurg.2004.12.024","article-title":"Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath","volume":"200","author":"Shapiro","year":"2005","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.transproceed.2011.05.032_bib22","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/TP.0b013e31816a8a6d","article-title":"Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody","volume":"85","author":"Shapiro","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2011.05.032_bib23","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1111\/j.1600-6143.2009.02710.x","article-title":"BAFF is increased in renal transplant patients following treatment with alemtuzumab","volume":"9","author":"Bloom","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2011.05.032_bib24","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1086\/510388","article-title":"Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody","volume":"44","author":"Peleg","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transproceed.2011.05.032_bib25","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1097\/TP.0b013e31819d3353","article-title":"Alemtuzumab (CAMPATH-1H) for the treatment of acute rejection in kidney transplant recipients: long-term follow-up","volume":"87","author":"Clatworthy","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2011.05.032_bib26","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.transproceed.2005.01.054","article-title":"Fungal infections in transplant recipients receiving alemtuzumab","volume":"37","author":"Nath","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2011.05.032_bib27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.diagmicrobio.2009.08.017","article-title":"Infections after the use of alemtuzumab in solid organ transplant recipients: a comparative study","volume":"66","author":"Safdar","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.transproceed.2011.05.032_bib28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/MOT.0b013e32832b45d0","article-title":"Alemtuzumab and liver transplantation: a review","volume":"14","author":"Dhesi","year":"2009","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.transproceed.2011.05.032_bib29","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1432-2277.2008.00642.x","article-title":"Alemtuzumab induction and triple maintenance immunotherapy in kidney transplantation from donors after cardiac death","volume":"21","author":"Schadde","year":"2008","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2011.05.032_bib30","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1034\/j.1600-6143.2003.00120.x","article-title":"Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study","volume":"3","author":"Knechtle","year":"2003","journal-title":"Am J Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134511007974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134511007974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T15:50:46Z","timestamp":1543593046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134511007974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0041134511007974"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2011.05.032","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}